Skip to content

Clinical trials

Terminated Thyroid Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Status: Terminated Country / region: United States Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20051
20061
20071
20083
20091
20121
20131
20142
20154
20163
20173
20183
20192
20202
20211
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
M.D. Anderson Cancer Center4
Medstar Health Research Institute3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
ABM Therapeutics Corporation1
Actym Therapeutics, Inc.1
Calando Pharmaceuticals1
Celgene1
Dana-Farber Cancer Institute1
Fore Biotherapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms37
Carcinoma, Non-Small-Cell Lung10
Melanoma10
Breast Neoplasms7
Carcinoma, Medullary7
Ovarian Neoplasms7
Thyroid Carcinoma, Anaplastic7
Colorectal Neoplasms6
Pancreatic Neoplasms6
Sarcoma6

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.